Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Culture

12 Aug 2023

Psychedelic Festivals: A Look at History, Culture, and Safety

We explore the history and cultural influence of psychedelic festivals, with a look at safety and harm-reduction practices within these transformative events....

By Microdose

Health & Wellness

11 Aug 2023

Promoting Healthy Aging: Can Psychedelic Therapy Enhance Quality of Life in Seniors?

As the population ages, there is a growing interest in finding new ways to promote healthy aging. Psychedelic therapies have emerged as a promising new approach, with the potential to...

By Microdose

Health & Wellness

10 Aug 2023

Creating Safe Spaces: The Role of Psychedelic Integration Circles

It's important to use psychedelics in a safe and supportive environment. This is where psychedelic integration comes in....

By Microdose

Health & Wellness

9 Aug 2023

Psychedelic-Assisted Therapy: Expanding Access and Ensuring Safety

it's important to ensure that psychedelic therapy is accessible to those who need it and is conducted in a safe and ethical manner....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture

6 Aug 2023

Exploring the Role of Music in Psychedelic Therapy and Culture

We take a look at how music can not only enhance the psychedelic experience but lead to better and more profound therapeutic outcomes....

By Microdose

Industry

4 Aug 2023

Affordable Ketamine Treatments: Interview With Dr. Bryan Henry of PsychMD

We sat down with PsychMD founder Bryan Henry to discuss the company’s ambitious roll-out and focus on affordable ketamine treatments....

By Microdose

Health & Wellness

3 Aug 2023

Deeper Healing: An Introduction to Psychedelic Integration

We explore integration in a psychedelic therapy setting and how it can enhance the therapeutic process....

By Microdose

Culture

2 Aug 2023

Barriers to Accessing Psychedelic Medicine: Exploring Solutions

Psychedelic medicine is making enormous strides. But many barriers still exist that hinder individuals from accessing psychedelic therapy....

By Microdose

Culture

1 Aug 2023

Psychedelic Culture: Past, Present, and Future

Psychedelic culture has a long and rich history. It has influenced music, art, and spirituality in profound ways. We take a closer look....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.